Profil
Alexander Pickett is the founder and the Managing Director of Juvenescence Ltd., a company founded in 2016.
He is currently working as a Director at Morphoceuticals, Inc.
Aktive Positionen von Alexander Pickett
| Unternehmen | Position | Beginn |
|---|---|---|
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Gründer | 01.01.2016 |
Morphoceuticals, Inc.
 Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Finance |
Morphoceuticals, Inc.
Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Commercial Services |